Asthma
Showing NaN - NaN of 151
Asthma Trial in Worldwide (BFF MDI 160/9.6 µg BID (320/19.2µg/day), BD MDI 160 µg BID (320 µg/day))
Recruiting
- Asthma
- BFF MDI 160/9.6 μg BID (320/19.2μg/day)
- BD MDI 160 μg BID (320 μg/day)
-
Huntington Beach, California
- +52 more
Mar 9, 2023
Asthma Trial in Worldwide (BGF MDI 320/28.8/9.6 µg, BGF MDI 320/14.4/9.6 µg, BFF MDI 320/9.6 µg)
Recruiting
- Asthma
- BGF MDI 320/28.8/9.6 μg
- +3 more
-
Birmingham, Alabama
- +423 more
Jan 18, 2023
Asthma Trial in Worldwide (BGF MDI 320/28.8/9.6 µg, BGF MDI 320/14.4/9.6 µg, BFF MDI 320/9.6 µg)
Recruiting
- Asthma
- BGF MDI 320/28.8/9.6 μg
- +3 more
-
Muscle Shoals, Alabama
- +387 more
Jan 18, 2023
Asthma Trial in Canada, United States (TEV-53275 Dose A, TEV-53275 Dose B, Placebo)
Terminated
- Asthma
- TEV-53275 Dose A
- +2 more
-
Hoover, Alabama
- +81 more
Dec 27, 2022
Observational Study of Obstructive Lung Disease (NOVELTY)
Active, not recruiting
- Asthma
- +2 more
- Blood draw
- +3 more
-
Loma Linda, California
- +302 more
Nov 22, 2022
Asthma Trial in Worldwide (FF/VI via ELLIPTA DPI, FF via ELLIPTA DPI)
Completed
- Asthma
- FF/VI via ELLIPTA DPI
- FF via ELLIPTA DPI
-
Hoover, Alabama
- +183 more
Sep 12, 2022
Asthma Trial in United States (Budesonide/Formoterol fumarate dihydrate, Symbicort, Placebo)
Completed
- Asthma
- Budesonide/Formoterol fumarate dihydrate
- +2 more
-
Birmingham, Alabama
- +94 more
Aug 1, 2022
Asthma Trial in Worldwide (BFF MDI 320/9.6 µg, BFF MDI 160/9.6 µg, BD MDI 320 µg)
Recruiting
- Asthma
- BFF MDI 320/9.6 μg
- +3 more
-
Saraland, Alabama
- +121 more
Aug 22, 2022
Asthma, COPD Trial in San Antonio (MGR001, Advair® Diskus®, Seretide™ Accuhaler™)
Completed
- Asthma
- COPD
- MGR001
- +2 more
-
San Antonio, TexasWorldwide Clinical Trials Early Phase Services
Feb 22, 2022
Asthma Trial in United States (MGR001 (Fixed dose combination of Fluticasone propionate and salmeterol xinafoate), Advair (Fixed
Completed
- Asthma
- MGR001 (Fixed dose combination of Fluticasone propionate and salmeterol xinafoate)
- +2 more
-
Birmingham, Alabama
- +100 more
Feb 22, 2022
Asthma Trial in Worldwide (GSK3511294 (Depemokimab), Placebo)
Recruiting
- Asthma
- GSK3511294 (Depemokimab)
- Placebo
-
Alabaster, Alabama
- +99 more
Dec 29, 2021
Asthma Trial in Worldwide (Experimental: Tezepelumab, Placebo)
Completed
- Asthma
- Experimental: Tezepelumab
- Placebo
-
Dothan, Alabama
- +288 more
Oct 29, 2021
Asthma Trial in Worldwide (Beclomethasone dipropionate, Placebo, Albuterol/salbutamol)
Completed
- Asthma
- Beclomethasone dipropionate
- +2 more
-
Costa Mesa, California
- +130 more
Nov 5, 2021
Asthma Trial in Raleigh, Edmond, San Antonio (Treatment A: Fp MDPI, Treatment B: FS MDPI, Treatment C Flovent)
Completed
- Asthma
- Treatment A: Fp MDPI
- +3 more
-
Raleigh, North Carolina
- +2 more
Nov 6, 2021